000			02034 a2200541 4500
005			20250514222806.0
264		0	_c20050628
008			200506s 0 0 eng d
022			_a1053-2498
024	7		_a10.1016/j.healun.2004.01.002 _2doi
040			_aNLM _beng _cNLM
100	1		_aHiggins, R
245	0	0	_aTo induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy? _h[electronic resource]
260			_bThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation _cApr 2005
300			_a392-400 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Multicenter Study
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntilymphocyte Serum _xtherapeutic use
650	0	4	_aDecision Making
650	0	4	_aFollow-Up Studies
650	0	4	_aGraft Rejection _xdrug therapy
650	0	4	_aHLA Antigens _ximmunology
650	0	4	_aHeart Transplantation
650	0	4	_aHumans
650	0	4	_aImmunosuppression Therapy _xmethods
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aMuromonab-CD3 _xtherapeutic use
650	0	4	_aNorth America _xepidemiology
650	0	4	_aPerioperative Care _xmethods
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aSeverity of Illness Index
650	0	4	_aSurvival Rate _xtrends
650	0	4	_aT-Lymphocytes _ximmunology
700	1		_aKirklin, J K
700	1		_aBrown, R N
700	1		_aRayburn, B K
700	1		_aWagoner, L
700	1		_aOren, R
700	1		_aMiller, L
700	1		_aFlattery, M
700	1		_aBourge, R C
773	0		_tThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation _gvol. 24 _gno. 4 _gp. 392-400
856	4	0	_uhttps://doi.org/10.1016/j.healun.2004.01.002 _zAvailable from publisher's website
999			_c15468333 _d15468333